ARISTADA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 31 Oct 2024)
What this means for you
Registered since 17 Jul 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87806402
- Registration number
- 5519704
- Mark type
- Design + words
- Filed
- 22 Feb 2018
- Published for opposition
- 01 May 2018
- Registered
- 17 Jul 2018
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases
Owner
- Alkermes Pharma Ireland Limited, Dublin, IE
- Alkermes Pharma Ireland Limited, Dublin, IE
- Alkermes Pharma Ireland Limited, Dublin, IE
Prior registrations
Prosecution history
- 31 Oct 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Oct 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 31 Oct 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 May 2024 — TEAS SECTION 8 & 15 RECEIVED
- 17 Jul 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Jul 2018 — REGISTERED-PRINCIPAL REGISTER
- 01 May 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 May 2018 — PUBLISHED FOR OPPOSITION
- 11 Apr 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Mar 2018 — ASSIGNED TO LIE
- 15 Mar 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Mar 2018 — EXAMINER'S AMENDMENT ENTERED
- 14 Mar 2018 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 Mar 2018 — EXAMINERS AMENDMENT E-MAILED
- 14 Mar 2018 — EXAMINERS AMENDMENT -WRITTEN